Navigation Links
Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications.

This groundbreaking research was recently featured in the leading Chemistry journal, Angewandte Chemie, and a United States patent has been filed on the invention.

Research Scientist Dr. Yu Han and IBN Executive Director Prof. Jackie Y. Ying have developed a fluorocarbon-mediated-synthesis technique that produces nanometer-sized particles of between 50 and 300 nm with tunable pore sizes in the range of 5-30 nm (The width of a human hair is approximately 80,000 nm).

“The nanoporous nanoparticles are named after our Institute, termed ‘IBN-1?to ‘IBN-5? They represent a new class of materials that are tailored simultaneously with nanometer-scale particle size and nanometer-sized pores. This is a beautiful example of ‘bottom-up?nanotechnology made possible by supramolecular chemistry,?said Prof. Ying.

Previous attempts at synthesizing such nanoparticles created particles that were limited in the type of structure, degree of structural ordering and range of pore sizes. Most current technologies can only produce 2-dimensional hexagonal structure with small pore diameter (< 5 nm). In many cases, special vapor-phase synthesis equipment is required.

IBN’s simple wet-chemical technique uses two different types of surfactant (a soluble chemical compound that reduces the surface tension between liquids). One surfactant acts as the template for mesoporous structure, while the other is used to limit the growth of the particles to nanometer dimensions.

This method can be used to create a variety of nanoparticles with enormous surface areas, and very well-defined pore size and structure.

One important application of these nanoporous nanoparticles lies in the production of pure chiral drugs, which m ake up over one-third of all pharmaceutical drugs currently sold worldwide. Chiral drugs are comprised of “left-handed?and “right-handed?molecules, both of which are mirror images of each other. Only one of these molecules provides the therapeutic effect. In the production process, catalysts are used to selectively synthesize the preferred chiral molecule that provides for therapeutic treatment without undesired side-effects. However, these catalysts normally exist in a homogeneous liquid phase, which makes them difficult to be separated and reused.

Prof. Ying’s group at IBN has developed novel approaches to immobilize these catalysts on nanoporous materials synthesized by its wet-chemical technique. This renders the catalysts in a solid form, enabling them to be easily recovered and reused through simple filtering or centrifuging processes. This allows for the more efficient synthesis of a wide variety of pharmaceuticals.

This improvement in the drug manufacturing process can potentially lead to greater cost savings, as the production of the chiral ingredient currently accounts for 10-40% of the total cost. IBN’s invention could potentially have a significant impact on the chiral pharmaceuticals industry, a fast-growing sector which generated US$143 billion sales in 2003.

Other applications of IBN’s nanoporous nanoparticles involve therapeutic treatments like targeted drug delivery and gene therapy. Nanoparticles of varying size and structure may be created to act as carriers for drugs, genes and proteins. In addition, these porous nanoparticles can be used to host quantum dots and magnetic nanoparticles for bioimaging and quantum device applications.


'"/>

Source:www.ibn.a-star.edu.sg


Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
3. Breakthrough isolating embryo-quality stem cells from blood
4. Breakthrough System for Understanding Ocean Plant Life Announced
5. Breakthrough: Scientists create worlds tiniest organic particles
6. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
7. Sciences Breakthrough of the Year: Watching evolution in action
8. Breakthrough for stem cell research
9. Breakthrough in understanding type-2 diabetes as key genes identified
10. Breakthrough vaccine to treat chemo-resistant ovarian cancer
11. Color-blind method opens new doors in DNA sequencing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... (PRWEB) , ... December 10, 2018 , ... ... a strategic alliance to advance their shared goal of accelerating the development of ... unique scale-up bioprocess systems to TRT’s core technology around human umbilical cord perivascular ...
(Date:12/5/2018)... ... 2018 , ... Quanta System announced today an exclusive distribution ... marketing of cutting-edge aesthetic devices in the US. Since inception in early 2017, ... success can be attributed in-part to the company’s independent business model which allows ...
(Date:12/5/2018)... ... December 04, 2018 , ... The ... IP in the development of innovative solutions for which high-speed imaging is a ... from microfluidics to industrial machinery and instrumentation, allowing partner companies to dedicate their ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... ... November 13, 2018 , ... Aditya ... technology market last week that asserts it is still trending upward with growing ... , Humad’s analysis describes market consolidation, pricing pressure and increased competition as reasons ...
(Date:11/13/2018)... ... November 13, 2018 , ... Sharon Kleyne, founder and new ... Pass, Oregon believes in the power of talk radio education Power of Water® ... the Power of Water® on talk radio every week with the “Sharon Kleyne ...
(Date:11/9/2018)... ... November 08, 2018 , ... uBiome, the leader in microbial ... and President of Andes Biotechnologies, to its Scientific Advisory Board. Joining the board ... uBiome expertise on the genetic studies of hepatitis viruses. The appointment will help ...
(Date:11/9/2018)... ... November 08, 2018 , ... Superior Controls, Inc. , ... with 140 employees on both the east and west coasts, today announced the ... Center on November 14 and 15 in Philadelphia. The event is hosted by ...
Breaking Biology Technology: